close 76% inwestorów detalicznych traci pieniądze podczas handlu CFD z tym dostawcą. Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej. 76% rachunków inwestorów detalicznych notuje stratę pieniędzy podczas handlu kontraktami CFD z tym dostawcą. Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Change languagePolski
Dashboard

LLY

745.48

-1.34%↓

JNJ

153.61

+0.7%↑

UNH

321.58

+1.9%↑

ABBV

184.82

-0.47%↓

NVO

68.12

+1.76%↑

LLY

745.48

-1.34%↓

JNJ

153.61

+0.7%↑

UNH

321.58

+1.9%↑

ABBV

184.82

-0.47%↓

NVO

68.12

+1.76%↑

LLY

745.48

-1.34%↓

JNJ

153.61

+0.7%↑

UNH

321.58

+1.9%↑

ABBV

184.82

-0.47%↓

NVO

68.12

+1.76%↑

LLY

745.48

-1.34%↓

JNJ

153.61

+0.7%↑

UNH

321.58

+1.9%↑

ABBV

184.82

-0.47%↓

NVO

68.12

+1.76%↑

LLY

745.48

-1.34%↓

JNJ

153.61

+0.7%↑

UNH

321.58

+1.9%↑

ABBV

184.82

-0.47%↓

NVO

68.12

+1.76%↑

Strona główna・Stock List・Karyopharm Therapeutics Inc
Search

Karyopharm Therapeutics Inc

Closed

SectorHealthcare

5.07 1

Strong Buy

Price update 20 maj 2025, 19:58 UTC

BuySell

Overview

Share price change

24h

Current

Min

4.89

Max

5.22

Key metrics

By Trading Economics

Income

1.3M

-31M

Sales

-8.2M

31M

EPS

-0.24

Profit margin

-100.779

Employees

279

EBITDA

972K

-20M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+593.36% upside

Market Stats

By TradingEconomics

Market Cap

53M

Previous open

4.07

Previous close

5.07

News Sentiment

By Acuity

50%

50%

179 / 382 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

5.9501 / 7.66 Support & Resistance

Karyopharm Therapeutics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

20 maj 2025, 20:54 UTC

Acquisitions, Mergers, Takeovers

PNC to Buy Private-Equity Agent Aqueduct Capital

DJ

Read

20 maj 2025, 20:50 UTC

Earnings

Palo Alto Networks Posts Higher 3Q Sales, Profit Slips

DJ

Read

20 maj 2025, 23:48 UTC

Acquisitions, Mergers, Takeovers

Kraft Heinz Evaluating Strategic Transactions, Berkshire Hathaway Steps Away From Board -- Update

DJ

Read

20 maj 2025, 23:42 UTC

Market Talk

Nikkei May Trade Rangebound Amid Tariff Uncertainty -- Market Talk

DJ

Read

20 maj 2025, 23:39 UTC

Market Talk

Gold Steady, Supported by Lingering U.S. Fiscal-Deficit Concerns -- Market Talk

DJ

Read

20 maj 2025, 23:08 UTC

Market Talk

James Hardie's Repair & Remodel Outlook Surprises RBC -- Market Talk

DJ

Read

20 maj 2025, 22:46 UTC

Acquisitions, Mergers, Takeovers

Gold Road: Takeover Remains Subject to Independent Expert Findings; Shareholder, Court Approval

DJ

Read

20 maj 2025, 22:45 UTC

Acquisitions, Mergers, Takeovers

Gold Road: Notified Australia Government Has No Objections to Takeover by Gold Fields

DJ

Read

20 maj 2025, 22:20 UTC

Top News

In Latest EV Pullback, Ford to Share Battery Plant With Nissan -- WSJ

DJ

Read

20 maj 2025, 22:00 UTC

Earnings

ZTO Express (Cayman) 1Q Adj EPS 37c >ZTO

DJ

Read

20 maj 2025, 22:00 UTC

Earnings

ZTO Express (Cayman) 1Q EPS 34c >ZTO

DJ

Read

20 maj 2025, 22:00 UTC

Earnings

ZTO Express (Cayman) 1Q Rev $1.5B >ZTO

DJ

Read

20 maj 2025, 21:44 UTC

Earnings

James Hardie Industries 4Q Adj EPS 36c >JHX

DJ

Read

20 maj 2025, 21:44 UTC

Earnings

James Hardie Industries: Sees FY26 North America Net Sales Growth Up Low Single Digits >JHX

DJ

Read

20 maj 2025, 21:44 UTC

Earnings

James Hardie Industries 4Q EPS 10c >JHX

DJ

Read

20 maj 2025, 21:44 UTC

Earnings

James Hardie Industries 4Q Sales $972M >JHX

DJ

Read

20 maj 2025, 20:52 UTC

Top News

Elon Musk to Cut Back Political Spending -- 3rd Update

DJ

Read

20 maj 2025, 20:52 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

DJ

Read

20 maj 2025, 20:52 UTC

Market Talk

Mexican Stocks Near Record High As Trade Concerns Ease -- Market Talk

DJ

Read

20 maj 2025, 20:30 UTC

Acquisitions, Mergers, Takeovers

PNC Financial: Aqueduct Acquisition Expected to Close in Mid-Summer, Terms Won't be Disclosed >PNC

DJ

Read

20 maj 2025, 20:28 UTC

Acquisitions, Mergers, Takeovers

PNC Bank Agrees To Acquire Aqueduct Capital Group To Complement Harris Williams Capabilities >PNC

DJ

Read

20 maj 2025, 20:23 UTC

Acquisitions, Mergers, Takeovers

Tesla CEO Musk Says He Plans to Be at White House for a Couple Days Every Few Weeks

DJ

Read

20 maj 2025, 20:22 UTC

Earnings

XP 1Q Adj EPS BRL2.29 >XP

DJ

Read

20 maj 2025, 20:22 UTC

Earnings

XP 1Q Rev BRL4.345B >XP

DJ

Read

20 maj 2025, 20:21 UTC

Acquisitions, Mergers, Takeovers

Tesla CEO Musk: 'We're in the Big Bang of Intelligence Explosion'

DJ

Read

20 maj 2025, 20:20 UTC

Top News

Fed's Bostic Signals Longer Delay in Cutting Interest Rates -- Barrons.com

DJ

Read

20 maj 2025, 20:19 UTC

Acquisitions, Mergers, Takeovers

Tesla CEO Musk Says He Doesn't Currently Have Plans to Merge Tesla, xAI

DJ

Read

20 maj 2025, 20:11 UTC

Top News

Venezuela Frees U.S. Air Force Veteran in Overture to Trump -- Update

DJ

Read

20 maj 2025, 20:09 UTC

Earnings

Palo Alto Networks 3Q Remaining Performance Obligation $13.5 B >PANW

DJ

Read

20 maj 2025, 20:08 UTC

Earnings

Palo Alto Networks Sees FY25 Adj EPS $3.26-Adj EPS $3.28 >PANW

DJ

Read

Peer Comparison

Price change

Karyopharm Therapeutics Inc Forecast

Price Target

By TipRanks

593.36% upside

12 Months Forecast

Average 35.5 USD  593.36%

High 105 USD

Low 8 USD

Based on 6 Wall Street analysts offering 12 month price targets forKaryopharm Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

6 ratings

5

Buy

1

Hold

0

Sell

Based on 6 analysts giving stock ratings to Karyopharm Therapeutics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

5.9501 / 7.66Support & Resistance

Short Term

Bullish Evidence

Recent bullish events outweigh bearish events.

Intermediate Term

Strong Bearish Evidence

All events are bearish.

Long Term

No Evidence

There are no events.

Sentiment

By Acuity

179 / 382 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

LLY

Eli Lilly and Co.

745.48

↓-1.34%

JNJ

Johnson and Johnson

153.61

↑ +0.7%

UNH

UnitedHealth Group Inc

321.58

↑ +1.9%

ABBV

AbbVie Inc

184.82

↓-0.47%

NVO

Novo Nordisk A-S

68.12

↑ +1.76%